Is Inmune Bio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: INMB) stock is to Buy INMB stock.
Out of 1 analyst, 0 (0%) are recommending INMB as a Strong Buy, 1 (100%) are recommending INMB as a Buy, 0 (0%) are recommending INMB as a Hold, 0 (0%) are recommending INMB as a Sell, and 0 (0%) are recommending INMB as a Strong Sell.
What is INMB's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: INMB) forecast ROE is N/A, which is considered weak.
What is INMB's Price Target?
According to 1 Wall Street analyst that have issued a 1 year INMB price target, the average INMB price target is $16.00, with the highest INMB stock price forecast at $16.00 and the lowest INMB stock price forecast at $16.00.
The Wall Street analyst predicted that Inmune Bio's share price could reach $16.00 by Jun 1, 2024. The average Inmune Bio stock price prediction forecasts a potential upside of 70.76% from the current INMB share price of $9.37.
What is INMB's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: INMB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.